Moderna vaccine progressing toward FDA approval
The coronavirus vaccine made by Moderna has moved closer to FDA authorization. Moderna would be the second company allowed to begin inoculating the U.S. public,...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The coronavirus vaccine made by Moderna has moved closer to FDA authorization. Moderna would be the second company allowed to begin inoculating the U.S. public,...
Over the fall semester, UConn has administered or tracked more than 42,000 COVID-19 individual and surveillance tests among its student body, helping it successfully complete...
Svigals + Partners, LLP is a full-service architecture firm offering architectural, master planning, interior design and FFE services. With nearly 40 years of professional experience,...
Boehringer Ingelheim plans to acquire NBE-Therapeutics, a private, clinical-stage Swiss biotechnology company focused on antibody-drug conjugates and advancing targeted cancer therapies derived from its immune stimulatory iADC™...
Recently released data confirm that Moderna’s coronavirus vaccine is highly protective, setting the stage for its emergency authorization this week by federal regulators and the...
Thetis Pharmaceuticals has received an FDA orphan drug designation for TP-317 as a small molecule, oral therapy for treatment of pediatric ulcerative colitis. “We are pleased...
Connecticut Innovations, the state’s venture capital and lending arm, has made $7.8 million worth of equity investments in its first quarter of fiscal year 2021...
Federal regulators have deemed a Woodbridge biotechnology company’s tumor-fighting therapy an ‘orphan’ drug, making it eligible for financial incentives. AlloMek Therapeutics earned the FDA designation...
InveniAI® and Kyowa Kirin have expanded their collaboration agreement to harness the power of InveniAI’s AI-platform, AlphaMeld®, for novel target discovery. Through this expansion, Kyowa Kirin will...
Eric Schadt, Ph.D., the Founder and CEO of Sema4, a patient-centered health intelligence company, has been named the 2020 BioCT Entrepreneur of the Year. The Entrepreneur of the Year award was...